Results 211 to 220 of about 395,793 (336)

Demonstrating the use of population level data to investigate trends in the rate, radiation dose and cost of Computed Tomography across clinical groups: Are there any areas of concern?

open access: yesJournal of Medical Radiation Sciences, EarlyView.
This repeated cross‐sectional study examined trends in CT use, costs and associated radiation dosages between high‐level clinical groups. CT use increased for most patient groups though the degree of increase varied between groups, while trends in costs and radiation dosages varied substantially between clinical groups. This work highlights areas which
Sviatlana Kamarova   +12 more
wiley   +1 more source

Development and evaluation of a health literacy scale for parasitic diseases. [PDF]

open access: yesBMC Infect Dis
Wang Y   +7 more
europepmc   +1 more source

Comparison of Bioluminescent Substrates in Natural Infection Models of Neglected Parasitic Diseases. [PDF]

open access: yesInt J Mol Sci, 2022
Hendrickx S   +9 more
europepmc   +1 more source

A historical perspective and prospects of biomedical research on parasitic diseases [PDF]

open access: gold, 2001
Augusto Simões-Barbosa   +2 more
openalex   +1 more source

Eosinophilic mesenteric vasculitis presenting as inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Inflammatory bowel disease (IBD), including Crohn's Disease (CD) and ulcerative colitis, is a chronic inflammatory condition affecting the gastrointestinal tract. Treatment for IBD depends on disease severity and can include medical and surgical management.
Razan Alkhouri   +7 more
wiley   +1 more source

Ultrasonography of Parasitic Diseases in Domestic Animals: A Systematic Review. [PDF]

open access: yesAnimals (Basel), 2022
Corda A   +7 more
europepmc   +1 more source

Targeting JAK‐1 in Disseminated Cutaneous Lichen Planus

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT We report the case of a 63‐year‐old woman with an exuberant and recalcitrant clinical presentation of LP who had an excellent response to 200 mg/day abrocitinib, a JAK‐1 inhibitor, after failure to other commonly used therapies. The efficacy of JAK inhibitors in lichen planus is supported by small case series and isolated case reports. Further
F. Barbosa, L. Siems, D. Luz, A. Duarte
wiley   +1 more source

Noninvasive diagnosis of liver fibrosis in schistosomiasis japonica: Opportunities and challenges

open access: yesPortal Hypertension & Cirrhosis, 2023
Tao Wang   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy